TY - JOUR
T1 - White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa
AU - Hoare, Jacqueline
AU - Fouche, Jean Paul
AU - Phillips, Nicole
AU - Joska, John A.
AU - Paul, Robert
AU - Donald, Kirsten A.
AU - Thomas, Kevin G.F.
AU - Stein, Dan J.
N1 - Publisher Copyright:
© Copyright 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015
Y1 - 2015
N2 - Objective: To describe the effect of HIV on white matter integrity and neurocognitive function in children vertically infected with HIV, compared to a HIV-negative healthy control group. Design: Cross-sectional. Methods: We compared 75 HIV-infected children aged 6-16 years, including children on antiretroviral therapy (ART) and those who were ART-naive, with 30 controls on diffusion tensor imaging and a neuropsychological battery sensitive to fronto-striatal pathology. In a secondary analysis, we compared 'slow progressor' ART-naive children, children on ART without a diagnosis of encephalopathy and children on ART with HIV encephalopathy. Results: Compared to controls (n=30), HIV-infected children (n=75) displayed decreased fractional anisotropy and axial diffusion, and increased mean diffusivity and radial diffusion, indicating damaged neuronal microstructure. HIV-infected children performed poorly on the neuropsychological battery (P=<0.001). Within the HIV-infected group, children with HIV encephalopathy (n=14) had poor white matter integrity when compared to ART-treated children without encephalopathy (n=41), and there was significant myelin loss in ART-naive children (n=20), compared with ARTtreated children. ART-treated children had significant axonal damage in the corpus callosum (P=0.009). Conclusion: Children infected with HIV, irrespective of treatment status, displayed significantly poorer white matter integrity and impaired cognition compared to HIVnegative controls. Our findings suggest that despite immune recovery in children on ART, they remain at risk for developing central nervous system disease, and that initiation of ART as early as possible may reduce the risk of developing white matter damage in ART-naive slow progressors.
AB - Objective: To describe the effect of HIV on white matter integrity and neurocognitive function in children vertically infected with HIV, compared to a HIV-negative healthy control group. Design: Cross-sectional. Methods: We compared 75 HIV-infected children aged 6-16 years, including children on antiretroviral therapy (ART) and those who were ART-naive, with 30 controls on diffusion tensor imaging and a neuropsychological battery sensitive to fronto-striatal pathology. In a secondary analysis, we compared 'slow progressor' ART-naive children, children on ART without a diagnosis of encephalopathy and children on ART with HIV encephalopathy. Results: Compared to controls (n=30), HIV-infected children (n=75) displayed decreased fractional anisotropy and axial diffusion, and increased mean diffusivity and radial diffusion, indicating damaged neuronal microstructure. HIV-infected children performed poorly on the neuropsychological battery (P=<0.001). Within the HIV-infected group, children with HIV encephalopathy (n=14) had poor white matter integrity when compared to ART-treated children without encephalopathy (n=41), and there was significant myelin loss in ART-naive children (n=20), compared with ARTtreated children. ART-treated children had significant axonal damage in the corpus callosum (P=0.009). Conclusion: Children infected with HIV, irrespective of treatment status, displayed significantly poorer white matter integrity and impaired cognition compared to HIVnegative controls. Our findings suggest that despite immune recovery in children on ART, they remain at risk for developing central nervous system disease, and that initiation of ART as early as possible may reduce the risk of developing white matter damage in ART-naive slow progressors.
KW - Cognitive impairment
KW - Diffusion tensor
KW - HIV/AIDS
KW - Imaging
KW - Pediatric
UR - http://www.scopus.com/inward/record.url?scp=84975166371&partnerID=8YFLogxK
U2 - 10.1097/QAD.0000000000000766
DO - 10.1097/QAD.0000000000000766
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26372385
AN - SCOPUS:84975166371
SN - 0269-9370
VL - 29
SP - 1793
EP - 1801
JO - AIDS
JF - AIDS
IS - 14
ER -